$275 Million is the total value of Monashee Investment Management LLC's 28 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 86.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | HYPERFINE INC | $3,886,000 | -37.5% | 1,742,490 | -0.7% | 1.41% | -21.4% | |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $3,261,000 | +87.4% | 1,230,441 | -3.1% | 1.19% | +135.5% |
| Sell | DOCGO INC | $2,749,000 | -27.4% | 385,058 | -6.0% | 1.00% | -8.8% | |
| Sell | AN2 THERAPEUTICS INC | $1,808,000 | -72.3% | 233,330 | -46.2% | 0.66% | -65.2% | |
| Exit | AFTERNEXT HEALTHTECH ACQUISI*w exp 99/99/999 | $0 | – | -50,318 | -100.0% | -0.01% | – | |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.03% | – |
| MQ | Exit | MARQETA INC-A | $0 | – | -15,000 | -100.0% | -0.05% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -369,099 | -100.0% | -0.09% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -10,000 | -100.0% | -0.14% | – |
| Exit | KINETIK HOLDINGS INC | $0 | – | -8,500 | -100.0% | -0.16% | – | |
| Exit | THORNE HEALTHTECH INC | $0 | – | -111,250 | -100.0% | -0.20% | – | |
| Exit | OMEGA THERAPEUTICS INC | $0 | – | -123,614 | -100.0% | -0.22% | – | |
| KREF | Exit | KKR REAL ESTATE FINANCE TRUS | $0 | – | -42,220 | -100.0% | -0.25% | – |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -158,196 | -100.0% | -0.33% | – | |
| Exit | XILIO THERAPEUTICS INC | $0 | – | -163,066 | -100.0% | -0.33% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -24,555 | -100.0% | -0.36% | – |
| NWN | Exit | NORTHWEST NATURAL GAS CO | $0 | – | -25,000 | -100.0% | -0.37% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -100,000 | -100.0% | -0.39% | – |
| HESM | Exit | HESS MIDSTREAM LP - CLASS A | $0 | – | -60,000 | -100.0% | -0.52% | – |
| Exit | ELIEM THERAPEUTICS INC | $0 | – | -227,201 | -100.0% | -0.55% | – | |
| NARI | Exit | INARI MEDICAL INC | $0 | – | -25,000 | -100.0% | -0.66% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.75% | – |
| Exit | ARCHAEA ENERGY INC | $0 | – | -130,000 | -100.0% | -0.83% | – | |
| PLL | Exit | PIEDMONT LITHIUM LTD-ADR | $0 | – | -40,000 | -100.0% | -0.85% | – |
| MYPS | Exit | PLAYSTUDIOS INC | $0 | – | -699,503 | -100.0% | -0.98% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -264,111 | -100.0% | -1.13% | – |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -470,000 | -100.0% | -1.25% | – | |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -236,991 | -100.0% | -1.62% | – |
| SWX | Exit | SOUTHWEST GAS HOLDINGS INC | $0 | – | -75,000 | -100.0% | -1.70% | – |
| SEDG | Exit | SOLAREDGE TECHNOLOGIES INC | $0 | – | -20,000 | -100.0% | -1.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
| VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
| SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
| BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
| COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
| BIOMX INC | 8 | Q3 2021 | 0.0% |
| AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
| COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
| WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
| FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-07 |
| 13F-HR | 2021-11-09 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.